Global Intussusception Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Intussusception Market Expected To Become By 2029 Compared With Its 2025 Level?

The intussusception market size has experienced consistent expansion in recent years. Its valuation is projected to increase from $4.45 billion in 2024 to $4.67 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.8%. This historical growth can be attributed to several factors including enhanced diagnostic capabilities, a rise in awareness and education, the expansion of global healthcare infrastructure, investments in research and development, and stronger collaboration among healthcare entities.

The intussusception market is projected to experience consistent expansion over the upcoming years. By 2029, its value is anticipated to reach $5.46 billion, exhibiting a compound annual growth rate (CAGR) of 4.0%. This anticipated growth during the projection period stems from factors such as ongoing medical education efforts, pediatric vaccination schemes, worldwide initiatives in pediatric healthcare, an emphasis on post-surgical care, increasing need for pediatric gastrointestinal studies, and the availability of telemedicine and remote health services. Key trends identified for the forecast timeframe encompass improvements in diagnostic imaging, less invasive treatment methods, the creation of interventions tailored for children, investigations into causes and risk factors, international epidemiological research, the execution of vaccination schedules, and the utilization of telemedicine for both diagnosis and consultations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

What Are The Main Drivers Boosting The Intussusception Industry’s Expansion?

The increasing occurrence of intestinal disorders is anticipated to boost the expansion of the intussusception market in the future. An intestinal disorder is defined as any medical condition or health problem that impairs the regular function of the intestines, which are components of the digestive system responsible for nutrient absorption and waste removal. A growing frequency of intestinal disorders, including inflammatory bowel disease and gastrointestinal cancers, can facilitate earlier detection, better treatment approaches, and increased assistance for intussusception patients, thereby improving their overall health and welfare. For example, data from January 2023, reported by the American Cancer Society (ACS), a US-based health organization focused on eradicating cancer, indicated a 3.18% rise in gastrointestinal cancers, reaching 348,840 from 338,090 in 2021 within the United States. Consequently, the heightened occurrence of intestinal disorders is poised to fuel the expansion of the intussusception market.

What Are The Emerging Segments Gaining Attention In The Intussusception Market?

The intussusceptionmarket covered in this report is segmented –

1) By Type: Idiopathic Intussusception; Secondary Intussusception

2) By Treatment: Enema Reduction; Surgery; Other Treatment

3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)

4) By End-User: Hospitals; Clinics; Other End-User

Subsegments:

1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception; Adult Idiopathic Intussusception

2) By Secondary Intussusception: Neoplastic Intussusception; Infectious Intussusception; Inflammatory Intussusception; Post-Surgical Intussusception

What Trends Are Redefining The Intussusception Market Dynamics?

Leading companies in the intestinal pseudo-obstruction treatment market are focused on creating new drug therapies, such as NHE3 inhibitor treatment therapy, to offer dependable solutions to customers. This NHE3 inhibitor treatment therapy functions as a medication by suppressing the Sodium-Proton-Exchanger subtype 3 (NHE3) within the gut. For instance, in April 2022, Ardelyx Inc., a US-based biopharmaceutical firm, introduced IBSRELA, an NHE3 inhibitor treatment for irritable bowel syndrome with constipation (IBS-C) in adults, potentially enhancing gastrointestinal motility. IBSRELA treatment therapy operates by inhibiting or blocking the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. Its approval was based on two Phase 3 trials involving more than 1,200 IBS-C patients, where it significantly improved abdominal pain and bowel movements, meeting the primary endpoint. These improvements were observed as early as Week 1 and sustained for 26 weeks in the long-term trial.

Which Leading Players Are Enhancing Their Intussusception Market Presence Worldwide?

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

What Regional Growth Trends Are Shaping The Intussusception Market Outlook?

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Intussusception Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13466&type=smp

Browse Through More Reports Similar to the Global Intussusception Market 2025, By The Business Research Company

Neuralgia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Pituitary Dwarf Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pituitary-dwarf-treatment-global-market-report

Tracheitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tracheitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795